- decreased mean corpuscular volume / IMPC
- increased circulating HDL cholesterol level / IMPC
- increased startle reflex / IMPC
- increased circulating triglyceride level / IMPC
- abnormal tail movements / IMPC
- decreased prepulse inhibition / IMPC
- increased lactate dehydrogenase level / IMPC
- increased circulating alanine transaminase level / IMPC
- increased circulating cholesterol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased locomotor activity / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased circulating serum albumin level / IMPC
B6J.129S2-Nr1h4tm1.1Ics/Ics
Status | Available to order |
EMMA ID | EM:12945 |
International strain name | B6J.129S2-Nr1h4tm1.1Ics/Ics |
Alternative name | FXRa CM |
Strain type | Targeted Mutant Strains : Conditional mutation |
Allele/Transgene symbol | Nr1h4tm1.1Ics |
Gene/Transgene symbol | Nr1h4 |
Information from provider
Provider | ICS, Institut Clinique de la Souris |
Provider affiliation | ICS, Institut Clinique de la Souris |
Genetic information | For detailed information on the genetic description of this strain, please have a look at this report. |
Phenotypic information | Homozygous:NAHeterozygous:NA |
Breeding history | 5 backcross generations |
References | None available |
Homozygous fertile | not known |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | not known |
Information from EMMA
Archiving centre | ICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Progressive familial intrahepatic cholestasis type 5 / Orphanet_480476
IMPC phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).